Onpattro Now Approved: Patient and HCP-facing pages Aug 30, 2018Aug 27, 2018 Brand: Onpattro (patisiran), Injection Parent Company: Alnylam Drug Type: Prescription Drug Category: Immunology Campaign: now-approved Targeting: HCPs, Patients, Caregivers Patient Website: https://www.onpattro.com/ HCP Website: https://www.onpattro.com/hcp/ Homepage (Patients) Alnylam Assist Sign Up (Patient form) Homepage (HCP) Homepage (Mobile, Patient) HCP Mobile Nav